265 related articles for article (PubMed ID: 15312049)
1. Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity.
Webb MR; Ebeler SE
Biochem J; 2004 Dec; 384(Pt 3):527-41. PubMed ID: 15312049
[TBL] [Abstract][Full Text] [Related]
2. Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I.
Das BB; Sen N; Roy A; Dasgupta SB; Ganguly A; Mohanta BC; Dinda B; Majumder HK
Nucleic Acids Res; 2006; 34(4):1121-32. PubMed ID: 16488884
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells.
Snyder RD; Gillies PJ
Environ Mol Mutagen; 2002; 40(4):266-76. PubMed ID: 12489117
[TBL] [Abstract][Full Text] [Related]
4. A gel electrophoresis assay for the simultaneous determination of topoisomerase I inhibition and DNA intercalation.
Webb MR; Ebeler SE
Anal Biochem; 2003 Oct; 321(1):22-30. PubMed ID: 12963051
[TBL] [Abstract][Full Text] [Related]
5. Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
Constantinou A; Mehta R; Runyan C; Rao K; Vaughan A; Moon R
J Nat Prod; 1995 Feb; 58(2):217-25. PubMed ID: 7769390
[TBL] [Abstract][Full Text] [Related]
6. DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin.
Bailly C; Riou JF; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M
Biochemistry; 1997 Apr; 36(13):3917-29. PubMed ID: 9092822
[TBL] [Abstract][Full Text] [Related]
7. Interaction of strong DNA-intercalating bioreductive compounds with topoisomerases I and II.
Rosenzweig HS; Papadopoulou MV; Bloomer WD
Oncol Res; 2005; 15(4):219-31. PubMed ID: 17822282
[TBL] [Abstract][Full Text] [Related]
8. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol.
Yamashita Y; Kawada S; Nakano H
Biochem Pharmacol; 1990 Feb; 39(4):737-44. PubMed ID: 2154993
[TBL] [Abstract][Full Text] [Related]
9. DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors.
Chen AY; Yu C; Gatto B; Liu LF
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8131-5. PubMed ID: 7690143
[TBL] [Abstract][Full Text] [Related]
10. Novel pyrazolo[3,4-d]pyrimidine with 4-(1H-benzimidazol-2-yl)-phenylamine as broad spectrum anticancer agents: Synthesis, cell based assay, topoisomerase inhibition, DNA intercalation and bovine serum albumin studies.
Singla P; Luxami V; Singh R; Tandon V; Paul K
Eur J Med Chem; 2017 Jan; 126():24-35. PubMed ID: 27744184
[TBL] [Abstract][Full Text] [Related]
11. Influence of elsamicin A on the activity of mammalian topoisomerase I.
Rodríguez-Campos A; Azorín F; Portugal J
Biochemistry; 1996 Aug; 35(34):11177-82. PubMed ID: 8780522
[TBL] [Abstract][Full Text] [Related]
12. The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro.
Constantinou A; Stoner GD; Mehta R; Rao K; Runyan C; Moon R
Nutr Cancer; 1995; 23(2):121-30. PubMed ID: 7644381
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin.
Cantero G; Campanella C; Mateos S; Cortés F
Mutagenesis; 2006 Sep; 21(5):321-5. PubMed ID: 16950806
[TBL] [Abstract][Full Text] [Related]
14. [DNA intercalators: their interaction with DNA and other cell components and their use in biological research].
Faddeeva MD; Beliaeva TN
Tsitologiia; 1991; 33(10):3-31. PubMed ID: 1814033
[TBL] [Abstract][Full Text] [Related]
15. DNA binding properties of 9-substituted harmine derivatives.
Cao R; Peng W; Chen H; Ma Y; Liu X; Hou X; Guan H; Xu A
Biochem Biophys Res Commun; 2005 Dec; 338(3):1557-63. PubMed ID: 16288723
[TBL] [Abstract][Full Text] [Related]
16. The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells.
López-Lázaro M; Willmore E; Austin CA
Mutat Res; 2010 Feb; 696(1):41-7. PubMed ID: 20025993
[TBL] [Abstract][Full Text] [Related]
17. AK37: the first pyridoacridine described capable of stabilizing the topoisomerase I cleavable complex.
Marshall KM; Holden JA; Koller A; Kashman Y; Copp BR; Barrows LR
Anticancer Drugs; 2004 Oct; 15(9):907-13. PubMed ID: 15457132
[TBL] [Abstract][Full Text] [Related]
18. Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors.
Shuai L; Wang S; Zhang L; Fu B; Zhou X
Chem Biodivers; 2009 Jun; 6(6):827-37. PubMed ID: 19551725
[TBL] [Abstract][Full Text] [Related]
19. Green tea constituents (-)-epigallocatechin-3-gallate (EGCG) and gallic acid induce topoisomerase I- and topoisomerase II-DNA complexes in cells mediated by pyrogallol-induced hydrogen peroxide.
López-Lázaro M; Calderón-Montaño JM; Burgos-Morón E; Austin CA
Mutagenesis; 2011 Jul; 26(4):489-98. PubMed ID: 21382914
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of topoisomerase I poisoning by a camptothecin analog.
Staker BL; Hjerrild K; Feese MD; Behnke CA; Burgin AB; Stewart L
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15387-92. PubMed ID: 12426403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
